Conversations with Mike Milken

Milken Institute•www.milkeninstitute.org

COVID-19 has changed the way we work and live. In response to the public health emergency, Milken Institute Chairman Michael Milken is engaging a range of industry leaders and medical experts to help us better understand and confront a crisis that has not only altered our current day-to-day but will change the course of how we work, socialize, and fight disease for years to come.

Last refreshed: July 26th, 2025 at 6:58 AM ⓘ

Follow this podcast in the Metacast mobile app to refresh it and see new episodes.

Follow on

Apple Podcasts

Spotify

RSS

Podcasts are better in Metacast mobile app

Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episodes

Ep. 6: Mobilization, with George Washington University’s Lynn Goldman

Joining Mike on this episode is Lynn Goldman. A pediatrician and epidemiologist, Goldman is the former assistant administrator for the Office of Chemical Safety and Pollution Prevention at the US Environmental Protection Agency, and the current Dean of the Milken Institute School of Public Health at George Washington University. With such an in-depth knowledge of epidemiology and related public policy, Goldman has been extremely busy in recent weeks. In her conversation with Mike, she describes ...

Apr 08, 2020•11 min•Season 1Ep. 6

Ep. 5: Breaking the Code, with Nobel Laureate David Baltimore

In this episode, Mike speaks with David Baltimore , a Nobel laureate, member of the FasterCures board, In this episode, Mike speaks with David Baltimore, a Nobel laureate, member of the FasterCures board, and the current president emeritus; Robert Andrews Millikan professor of biology at the California Institute of Technology. Based on his extensive research into genetics and virology, Baltimore describes the different challenges posed by COVID-19 , and how it compares to the progress made on pr...

Apr 07, 2020•14 min•Season 1Ep. 5

Ep. 4: Moonshot, with Johnson & Johnson’s Alex Gorsky

Alex Gorsky Chairman and CEO, Johnson & Johnson “What we announced that day was that we have identified a lead candidate for COVID-19 vaccine…. This is a bit of a moonshot for us.” That’s Johnson & Johnson CEO Alex Gorsky talking about the $1 billion partnership his company formed with BARDA, the U.S. Biomedical Advanced Research and Development Authority. The company is ramping up so that if the accelerated clinical trials are successful, J&J will be prepared to produce and ship by ...

Apr 07, 2020•14 min•Season 1Ep. 4

Ep. 3: Physician Heal Thyself, with Allogene’s Arie Belldegrun

Mike speaks with Arie Belldegrun , an oncologist and businessman who has built several biopharmaceutical companies over the past three decades. Both Belldegrun and his wife recently recovered from their positive diagnoses of COVID-19, though it presented very differently in each of their cases. Bringing together his years of research and personal experience with the virus, Belledgrun discusses the role the immune system plays in both protecting the body from and preparing it to fight against the...

Apr 06, 2020•18 min•Season 1Ep. 3

Ep. 2: Grand Rounds, with Providence’s Rod Hochman

Mike Milken speaks with Rod Hochman , chair-elect designate for the American Hospital Association and president and CEO of Providence St. Joseph Health, the third-largest health-care system in the United States. With 51 hospitals, 1,000 clinics, and 120,000 frontline caregivers across the seven western states, the Providence St. Joseph team in Seattle successfully identified and treated the very first case of COVID-19 in the United States back in January. Hochman shares what they’ve learned from...

Apr 06, 2020•25 min•Season 1Ep. 2

Ep. 1: Big Science, with NIH’s Francis Collins

Francis Collins Director, National Institutes of Health “We have on our own campus the vaccine research center that is working 24/7 to accelerate the progress with as many different vaccines as possible, but particularly one that is already in phase one trials.” Francis Collins was born for big science. After a successful 13-year effort leading 2,400 scientists in six countries to crack the human DNA instruction book, the one-time leader of the Human Genome Project now is now directing the large...

Apr 06, 2020•17 min•Season 1Ep. 1

← Prev

For the best experience, listen in Metacast app for iOS or Android